Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

Model Approaches for Pharmacokinetic Data: Compartment Models

Model Approaches for Pharmacokinetic Data: Compartment Models

Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

From removal claims to engineering evidence: electrochemical treatment and selective recovery of heavy metals in wastewater.

Nanoscale·2026

Same author

Establishment of an LNA-TaqMan fluorescent quantitative PCR assay for differential diagnosis of virulent and attenuated strains of short beak and dwarfism syndrome virus.

Avian pathology : journal of the W.V.P.A·2026

Same author

Assembly and comparison of organelle genomes for investigating the maternal inheritance in Peganum (Nitrariaceae).

BMC genomics·2026

Same author

Correction: A High-quality chromosome-level genome assembly of Swertia przewalskii Pissjauk.

Scientific data·2026

Same author

Coexistence of Dirac Nodal Lines and Rashba Bands in the Topological Superconductor Candidate AuSn<sub>4</sub>.

Nano letters·2026

Same author

Editorial: Targeting non-coding RNAs in viral disease management: potential as therapeutic targets and diagnostic biomarkers.

Frontiers in cellular and infection microbiology·2026

Search research articles

Related Experiment Video

Updated: Mar 17, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

Computational Study of Drugs by Integrating Omics Data with Kernel Methods.

Yongcui C Wang¹, Naiyang Deng², Shilong Chen³

¹Key Laboratory of Adaptation and Evolution of Plateau Biota, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, No. 23, Xinning Road, Xining, Qinghai Province, P. R. China.

Molecular Informatics

|August 3, 2016

Summary

Kernel methods integrate diverse omics data to computationally study drugs, improving drug target prediction, ATC-code assignment, and drug repositioning for efficient drug discovery.

Keywords:

ATC-codes of drugs Data integration Drug repositioning Drug-targets Kernel methods Omics data

More Related Videos

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

Related Experiment Videos

Last Updated: Mar 17, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

Area of Science:

Computational biology
Cheminformatics
Genomics

Background:

Publicly available omics data sources offer insights into drug functions at various biological levels.
Integrating these diverse data sources is crucial for a comprehensive understanding of drug mechanisms.

Purpose of the Study:

To review recent advancements in kernel-based methods for integrating drug-related omics data.
To demonstrate the application of these methods in predicting drug targets, assigning ATC codes, and identifying drug repositioning opportunities.

Main Methods:

Development and application of kernel-based computational frameworks.
Integration of heterogeneous omics data sources (genomic, chemogenomic).
Utilizing machine learning algorithms for data mining and rule learning.

Main Results:

Data integration significantly improves accuracy in predicting drug targets, ATC codes, and drug repositioning.
Novel predictions supported by database searches and functional analysis were identified.
Kernel methods demonstrated efficiency in recovering experimentally validated information.

Conclusions:

Kernel methods provide an efficient approach to integrate heterogeneous data for computational drug studies.
This integration facilitates low-cost drug discovery research and promotes further experimental validation.